Rationale: Neuronal calcium sensor-1 (NCS-1) regulates various neuronal functions. Although it is expressed in the heart, very little is known about its cardiac functions.
C alcium regulates various cellular processes and is responsible for activating myocyte contraction via excitation-contraction (EC) coupling and stimulating the gene transcription underlying hypertrophy. 1 In adult ventricular muscles, propagation of the action potential initiates sarcolemmal Ca 2ϩ entry through voltage-gated L-type Ca 2ϩ channels, which triggers Ca 2ϩ release from the sarcoplasmic reticulum (SR) Ca 2ϩ stores. These whole-cell transients can be described by spatiotemporal summation of the local Ca 2ϩ transients that arise from SR Ca 2ϩ -release channel ryanodine receptors (RyR2s) at T-tubule SR junctions, which leads to contraction. 2 Myocytes in the immature heart are structurally and functionally different from those in the mature heart 3 : The T-tubule network is largely absent, 4 the SR is sparse, 3 and expression levels of Ca 2ϩ regulatory proteins are different. 5 Although L-type Ca 2ϩ channel activity and RyR expression are low in the fetal heart and increase during development, T-type Ca 2ϩ channel activity and Na ϩ /Ca 2ϩ exchanger 1 (NCX1) expression peak near birth and decline postnatally. 6 RyR2s mainly mediate the release of SR Ca 2ϩ , whereas cardiomyocytes also express inositol 1,4,5-trisphosphate receptor (IP 3 R), a Ca 2ϩ release channel. Because IP 3 R expression is considerably lower than RyR expression in myocytes, the role of inositol 1,4,5-trisphosphate (IP 3 )-mediated Ca 2ϩ signaling in cardiomyocytes is yet unknown; however, recent evidence suggests that IP 3 Rs play an important role in cardiac function, especially in immature 7, 8 and diseased 7, 9 hearts. For example, IP 3 Rs play a crucial role in heart development in early embryonic mice by enabling the initiation of pacemaking activity, thereby promoting cardiogenesis. 7, 8 Thus, the mechanism of EC coupling in the immature heart differs from that observed in adult hearts; however, the detailed molecular mechanisms of this event are not yet completely understood.
Hypertrophic enlargement of the heart occurs during development and in response to physiological stimuli or pathological insults. Progression of hypertrophy is commonly accompanied by complex changes in the expression of genes Original received February 7, 2011 ; resubmission received May 18, 2011 ; revision received June 24, 2011 ; accepted June 27, 2011. In May 2011, the average time from submission to first decision for all original research papers submitted to Circulation Research was 14.5 days.
such as "fetal program" genes, which show higher expression levels in immature hearts. 1 Although the detailed mechanisms of cardiac hypertrophy have been reported, molecules involved in its regulation may still be missing.
Here, we identified neuronal calcium sensor-1 (NCS-1) as a previously unrecognized regulator of EC coupling in young hearts and of hypertrophy in adults. NCS-1 is a small (22 kDa ) N-terminal myristoylated Ca 2ϩ -binding protein that contains 4 EF-hand motifs, 3 of which (EF2 through EF4) bind to Ca 2ϩ in the physiological range. 10 On binding Ca 2ϩ , NCS-1 undergoes large conformational changes and regulates a variety of its target proteins, such as phosphatidylinositol 4-hydroxykinase, 11 some voltage-gated ion channels, [12] [13] [14] [15] and the D2 (dopamine) receptor. 16 Although low NCS-1 levels are found in almost all tissues, NCS-1 is mainly expressed in the brain and heart. 10,17 NCS-1 has been studied extensively for its functions in neurons and neuroendocrine cells, and studies have demonstrated its importance for neurotransmitter release, 18 synaptic plasticity, 19, 20 learning and memory, 20, 21 and neuronal survival. 22 Recently, NCS-1 was reported to be involved in paclitaxel-induced spontaneous Ca 2ϩ oscillation in cardiomyocytes. 23 However, little evidence is available for its physiological and pathological roles in cardiac functions, possibly because of its relatively low expression in the adult heart. We previously detected high expression levels (comparable to the levels in neurons) of NCS-1 in immature hearts 17 and hypertrophic hearts overexpressing Na ϩ /H ϩ exchanger 24 (data not shown); therefore, we hypothesized that NCS-1 has a specific role in cardiac function, particularly at the immature stage and during progression of hypertrophy.
To validate these hypotheses, we investigated the function of NCS-1 in the heart using Ncs1-knockout (Ncs1 Ϫ/Ϫ ) mice. NCS-1 was found to increase IP 3 R-dependent Ca 2ϩ signaling, which in turn activates Ca 2ϩ /calmodulin-dependent protein kinase II (CaMKII)-dependent pathways, consequently promoting contraction in young hearts. Our results also demonstrated that NCS-1 promotes receptor stimulation-induced cardiac hypertrophy by activating both CaMKII-and calcineurin-dependent pathways in adults. These observations suggest additional mechanisms of EC coupling in young hearts and regulation of hypertrophy. 
Methods

Results
NCS-1 at the Immature Stage
We investigated NCS-1 expression during heart development in detail. We found higher NCS-1 expression at the fetal and neonatal stages, which gradually decreased after 2 weeks of birth ( Figure 1A ). Expression levels were comparable in the atria and ventricles at the same age ( Figure 1B) . Immunofluorescence analysis revealed that NCS-1 was predominantly localized to the plasma membrane and perinuclear regions, particularly at the nuclear envelope and SR, in ␣-actinin-positive cardiac myocytes (Online Figure I ).
Diminished Systolic Function in Young
To determine the cardiac role of NCS-1, we obtained global Ncs1 Ϫ/Ϫ mice that exhibited a complete absence of NCS-1 protein in the heart ( Figure 1C ). These mice had a high mortality rate, specifically at the neonatal stage (approximately 4 days after birth; Figure 1D ). Furthermore, the body weights of these mice were higher than those of wild-type (WT) mice after 2 months ( Figure 1E) ; however, the underlying mechanisms for this weight increase are unknown. To analyze cardiac functions at different developmental stages, we selected 2-week-old juveniles (immature but that could be reliably measured echocardiographically), 6-week-old young adults (similar body weights), and 4-month-old adults (significantly different body weights). The overall whole-heart structures were similar among the mice at all ages ( Figure  1F) ; however, echocardiographic analysis revealed considerably diminished ventricular function in the 2-week-old Ncs1 Ϫ/Ϫ mice, which resulted in a reduced percentage of fractional shortening and ejection fraction ( Figure 1G ; Online Table I ). However, such reduced ventricular functions were observed to a lesser extent in the 6-week-old and 4-month-old mice ( Figure 1H ; Online Figure II ; Online Table I Figure 3A) , phosphorylation levels of CaMKII-␦ ( Figure 3B ) and CaMKII-dependent phosphorylation of phospholamban at Thr17, a Ca 2ϩ -pump regulatory protein, in the Ncs1
hearts were almost half those of the WT mice, with no difference at Ser16, which is a protein kinase A phosphorylation site ( Figure 3C ). Furthermore, the rate of decline in the field stimulation-elicited Ca 2ϩ transient was significantly slower in the Ncs1 Ϫ/Ϫ myocytes ( Figure 3D ), wherein the time constant increased to 150% of the WT, which indicates slower Ca 2ϩ removal, mainly by SR Ca A, NCS-1 levels normalized to endogenous GAPDH levels during development in WT mouse heart. E14 indicates 14-day-old embryos; P4, 4-day-old neonates; 1 to 3 w, 1-to 3-week-old juveniles (nϭ8/group); and 1 to 2 m, 1-to 2-month-old adults (nϭ3/group). B, Similar NCS-1 expression was observed in the atria and ventricles of 4-week-old mice (nϭ3/group). C, NCS-1 protein was absent in the Ncs1 Ϫ/Ϫ mouse heart. D, Kaplan-Meier survival curve analyzed by log-rank test showed that young Ncs1 Ϫ/Ϫ mice had a reduced survival rate ( 2 ϭ16.76 with associated PϽ0.0001, nϭ100/group). E, Time course of changes in the body weights of WT and Ncs1 Ϫ/Ϫ mice (nϭ5 to 8 mice per group). PϽ0.05 for all mice Ͼ2 months of age. F, Hematoxylin-and-eosin-stained cardiac sections of mice at different ages. Scale barsϭ1 mm. G and H, Representative M-mode echocardiographic images from 2-week-old (G) and 6-week-old (H) WT and Ncs1 Ϫ/Ϫ mice, which indicate that Ncs1 deletion induces diminished contractile functions in young mouse hearts (nϭ6/group). *PϽ0.05 vs WT. LVIDd and LVIDs indicate left ventricular diastolic and systolic internal dimension, respectively; LVID, left ventricular internal dimension; and FS, fractional shortening.
pumping. Therefore, fewer CaMKII-␦ and phospholamban activities, leading to less SR Ca 2ϩ loading and release, would be the mechanism underlying the decrease in systolic Ca 2ϩ levels in Ncs1 Ϫ/Ϫ myocytes at the immature stage. On the other hand, there were few differences in the total and phosphorylated CaMKII and phospholamban levels in 6-week-old adult hearts between the WT and Ncs1 Ϫ/Ϫ mice ( Figures 3B and 3C) . Furthermore, the total CaMKII-␦ and phosphorylated CaMKII expression levels were significantly higher at the immature stage ( Figure  3E ), which suggests that CaMKII signaling is more important in immature hearts, and NCS-1 may be involved in such signaling. In addition, when NMVMs were pretreated by the CaMKII inhibitor KN93 (but not its inactive analog KN92; data not shown), the Ca 2ϩ transient of WT myocytes was decreased significantly, but that of knockout myocytes decreased to a lesser extent, thus normalizing the difference between the WT and knockout groups ( Figure  2A ). These findings supported our hypothesis that the function of NCS-1 is largely mediated via CaMKII activation in immature hearts.
Physical and Functional Interaction of NCS-1 With Cardiac IP 3 Rs
To identify the cardiac Ca 2ϩ source that activates CaMKII in WT immature hearts, we searched for proteins that interact with NCS-1. As previously reported in neurons 25 and recently in hearts, 23 we also detected that both IP 3 R1 and IP 3 R2 immunoprecipitated and colocalized with NCS-1 in HEK293 cells that overexpressed NCS-1 plus IP 3 R1 or IP 3 R2 (Online Figure III , B and C) and in primary cultured NMVMs (Online Figure III , D and E). NCS-1 proteins colocalized with IP 3 Rs predominantly at the perinuclear region. Furthermore, endogenous NCS-1 interacted with IP 3 Rs in native heart homogenates from WT mice (but not from NCS-1 Ϫ/Ϫ mice) in the presence of Ca 2ϩ (50 mol/L), whereas no interaction was detected in the absence of Ca 2ϩ , which demonstrates that the NCS-1-IP 3 R association is Ca 2ϩ dependent. Furthermore, no interaction was detected in transgenic mice that overexpressed the NCS-1 mutant E120Q, which has little affinity for Ca 2ϩ binding ( Figure 4A ). Such a Ca 2ϩ -dependent association of NCS-1 and IP 3 Rs is at least because the function and the conformation of NCS-1 is Ca 2ϩ dependent. Similar to NCS-1 and CaMKII, the expression level of IP 3 R2 was significantly higher at the neonatal stage ( Figure 4B ), which suggests that all NCS-1, CaMKII, and IP 3 Rs may have a crucial role in immature heart function. We next examined the effect of knocking out the NCS-1 gene on cardiac IP 3 R function. When ATP (which induces IP 3 release) was applied to spontaneously beating NMVMs, it potently increased both the diastolic and systolic levels of Ca 2ϩ in WT myocytes. This effect was significantly reduced in Ncs1 Ϫ/Ϫ myocytes ( Figure 4C ). Similar results were obtained in the absence of extracellular Ca 2ϩ ( Figure  4D ), in which the effect of ATP was mainly mediated via IP 3 R activation and not via sarcolemmal Ca 2ϩ entry, or with the membrane-permeable IP 3 ester adenophostin A. These effects were also blocked by the IP 3 R inhibitor Ϫ/Ϫ (KO) mouse hearts (8 hearts per group). CSQ indicates calsequestrin. B and C, Representative immunoblots of total and phosphorylated CaMKII-␦ (B), phospholamban (PLB; C), and GAPDH in 1-week-old juvenile and adult mouse hearts. The average phosphorylated levels normalized to the total levels indicate that the phosphorylation levels of CaMKII-␦ and PLB at Thr17 (CaMKII phosphorylation site) were lower in the hearts of immature Ncs1 Ϫ/Ϫ mice. S16 and Se16 indicate Ser16; T17 and Th17, Thr17. D, Slower Ca 2ϩ decline indicates lower SR Ca 2ϩ pump activity in Ncs1 Ϫ/Ϫ myocytes. Electric stimulation (ES)-elicited Ca 2ϩ transients (0.5 Hz) were normalized to adjust the peak amplitude of WT and KO myocytes, and the time constants () were obtained by fitting the decline phase with the first-order exponential decay (bar graph; nϭ18 transients from 3 WT and 3 Ncs1 Ϫ/Ϫ hearts). *PϽ0.05 vs WT. E, Expression levels of CaMKII-␦ and phosphorylated CaMKII in WT mouse hearts during development. Figure 4E ). These results demonstrate that NCS-1 enhances Ca 2ϩ release from intracellular stores through IP 3 R activation.
2-aminoethoxydiphenyl borate (
NCS-1-Mediated Hormone-Induced Cardiac Hypertrophy
Genes expressed at high levels at the immature stage are often upregulated in hormone-induced cardiac remodeling. 1 When NMVMs were treated with the ␣1-adrenergic receptor agonist phenylephrine (PE) or endothelin-1, NCS-1 expression was increased ( Figure 5A ). In addition, NCS-1 overexpression induced by adenoviral infection resulted in morphological changes in the cultured NMVMs, as observed when hypertrophic stimuli were applied; myocytes grouped together ( Figure 5B), and their contractions became stronger (data not shown). Furthermore, NCS-1 overexpression induced the increased expression of the hypertrophy-related gene ANP (atrial natriuretic peptide), and this effect was largely prevented by pretreatment of the myocytes with 2-aminoethoxydiphenyl borate ( Figure 5C ). These results suggest that NCS-1 is involved in cardiac hypertrophy possibly via IP 3 signaling activation.
Then, we examined whether NCS-1 deletion prevented receptor agonist-induced hypertrophy in vivo. When WT mice were treated with constant PE infusion, they exhibited marked cardiac hypertrophy, which was revealed by the increased heart weight-to-body weight ratio, fibrosis, myocyte area ( Figures 6A through 6C, respectively) , and expression of several hypertrophy markers, including ANP, braintype natriuretic peptide, and ␤-myosin heavy chain ( Figure  6D ). In contrast, these PE-induced effects were markedly prevented in the Ncs1 Ϫ/Ϫ hearts ( Figures 6A through 6D ). In addition, NCS-1 expression levels (both mRNA and protein) were increased significantly ( Figure 6E ). These results suggest that ␣1-adrenergic receptor stimulation-induced cardiac hypertrophy is mediated at least in part by NCS-1.
Furthermore, although the level of phosphorylated CaMKII was markedly increased in PE-treated WT hearts, no increment was detected in Ncs1 Ϫ/Ϫ hearts ( Figure 7A ). Similarly, protein and mRNA levels of MCIP/RCAN1 (modulatory calcineurin-interacting protein 1/regulator of calcineurin 1), which was used as a sensitive indicator of calcineurin activity, were elevated in PE-treated WT hearts but not in Ncs1 Ϫ/Ϫ hearts ( Figure 7B ). In addition, overexpression of and endothelin-1 (ET-1; 5 nmol/L) for 3 days resulted in increased NCS-1 expression. NCS-1 expression was normalized to the GAPDH level. Con indicates control. B, NCS-1 overexpression in NMVMs with adenovirus (Ad) showed morphological changes (nϭ12 dishes/group). C, Immunostaining of NMVMs for atrial natriuretic peptide (green) and ␣-actinin (red). NMVMs were pretreated with or without 2-aminoethoxydiphenyl borate (2-APB), KN93, or FK506 (inhibitors for IP 3 Rs, CaMKII, and calcineurin, respectively) under serum-free conditions for 12 hours. They were then infected with Ad-NCS-1, and immunostaining was performed after 2 days (nϭ5 dishes/group). *PϽ0.05. Scale barsϭ20 m.
NCS-1 significantly increased the activity of NFAT (nuclear factor of activated T cell) in myocytes carrying the NFATluciferase reporter transgene (Online Figure IV, C) . These results indicate that both the CaMKII-and calcineurindependent pathways are activated in the hypertrophic heart, and the extent of their activation depends on NCS-1 levels. This notion was further supported by the evidence that both CaMKII and calcineurin inhibitors prevented NCS-1-induced hypertrophy, which was evaluated by expression of atrial natriuretic factor ( Figure 5C ). However, other signal transduction pathways such as ERK42/44 and p38 mitogen-activated protein kinases remained unchanged by NCS-1 expression (Online Figure IV, D) .
To further confirm the link between NCS-1, IP 3 R, and CaMKII activation, we used a heterologous overexpression system. When HEK293 cells were transfected with 
Relative mRNA Expression
CaMKII-␦ with or without IP 3 R2 and NCS-1, the levels of phosphorylated CaMKII were significantly increased in the cells that overexpressed NCS-1 and IP 3 R2 ( Figure 7C ). Furthermore, when these cells were exposed to the IP 3 R agonist adenophostin A, CaMKII phosphorylation increased in a time-dependent manner, which was prevented by pretreatment with 2-aminoethoxydiphenyl borate ( Figure 7D ). These results illustrate a functional correlation between NCS-1 and CaMKII, as well as between IP 3 R stimulation and CaMKII activation.
Discussion
In the present study, we identified 2 novel roles of NCS-1 in cardiac tissues: positive regulation of contraction in immature hearts and of hypertrophy in adults. The Ca 2ϩ regulatory mechanism in the immature heart is considered to be different from that in the adult heart. The embryonic heart is considered more dependent on transsarcolemmal Ca 2ϩ flux, eg, through an Na ϩ /Ca 2ϩ exchanger and T-type Ca 2ϩ channel. However, accumulated evidence suggests that SR maturation during neonatal development positions it as the primary source of Ca 2ϩ for contraction. 5 Therefore, additional factors might enhance SR-dependent EC coupling, particularly in the postnatal stage. We found that NCS-1, which is a cardiac Ca 2ϩ signaling regulator, enhances EC coupling in young hearts. Because of the decreased intracellular Ca 2ϩ transient amplitude and SR Ca 2ϩ content in the heart, Ncs1 Ϫ/Ϫ mice exhibited diminished systolic functions, specifically at the young stage. Moreover, phosphorylation of CaMKII, CaMKII-dependent phosphorylation of phospholamban, and Ca 2ϩ pump activity also decreased in Ncs1 Ϫ/Ϫ myocytes. These results indicate that NCS-1 activates CaMKII signaling, thereby enhancing SR-dependent EC coupling, which is otherwise inefficient because of the structural immaturity of the young heart. In line with this hypothesis, we observed significantly higher levels of total and phosphorylated CaM-KII in the hearts of immature mice than in those of adult mice ( Figure 3E) , and the T-tubule network was still largely absent in both WT and Ncs1 Ϫ/Ϫ mice at this age (Online Figure V) . In healthy adult hearts, however, the EC coupling mechanism largely depended on the L-type Ca 2ϩ channel and RyRs, with mature SR and T-tubule structures (Online Figure V) , and this mechanism may be less dependent on the functions of NCS-1, IP 3 Rs, and CaMKII, because low expression levels of these molecules were detected. This could explain in part the small difference observed in ventricular function between adult WT and Ncs1 Ϫ/Ϫ mice (Online Table I ). NCS-1 was associated with IP 3 Rs and promoted IP 3 -induced Ca 2ϩ release in cardiac cells. This finding is consistent with those of previous reports that have demonstrated that NCS-1 enhances IP 3 R activity when monitored as the activity of single channels and as Ca 2ϩ transients in intact cells. 23, 25 In addition, the present experiments using the overexpression system were able to directly demonstrate that IP 3 R activation results in CaMKII-␦ phosphorylation, and this was further enhanced by NCS-1 overexpression ( Figures  7C and 7D ), which supports a functional link between NCS-1, IP 3 R, and CaMKII activation. The present experiments showed that CaMKII-␦ and NCS-1, which were overexpressed in HEK293 cells, did not coimmunoprecipitate or colocalize with each other (Online Figure VI) , which rules out possible direct interactions between NCS-1 and CaMKII-␦ independent of the effects of NCS-1 on IP 3 R. Taken together, these results suggest that NCS-1-IP 3 R interactions could serve as a Ca 2ϩ source for the activation of CaMKII, leading to a higher rate of SR Ca 2ϩ pumping and release and inducing global Ca 2ϩ signaling, thus promoting EC coupling in immature hearts (Online Figure VII depicts a  possible signaling pathway) .
One of the mechanisms of the early lethality observed in Ncs1 Ϫ/Ϫ mice might be the insufficient release of Ca 2ϩ from IP 3 Rs at this age, as mentioned in a recent report that demonstrated that double knockout of IP 3 R1 and IP 3 R2 genes resulted in embryonic death. 26 However, other possibilities such as the reduced stress tolerance of Ncs1 Ϫ/Ϫ mice should be investigated. Because the major findings obtained with in vivo whole hearts (Figures 1, 3 , and 6) were also obtained with isolated NMVMs that were free of neuronal systems (Figures 2, 4 , and 5), we believe that the present findings are primarily from the heart tissue; however, the neurological consequences of a global NCS-1 knockout that may affect heart function should also be considered. Ca 2ϩ plays a pivotal role in the transcription of genes involved in cardiac hypertrophy. We demonstrated another important role of NCS-1 as a novel regulator of cardiac hypertrophy. The expression level of NCS-1 was increased significantly in hypertrophic hearts at the transcriptional level. The increased protein was detected as early as 2 days after PE infusion in the in vivo hearts (Online Figure IV, A) , which suggests that NCS-1 has a role in the early stage of hypertrophy. As expected, PE-induced hypertrophy was largely attenuated in Ncs1 Ϫ/Ϫ mouse hearts. Because NCS-1 physically and functionally interacted with cardiac IP 3 Rs, which reportedly function as hypertrophic effectors in vivo, 27 we hypothesized that PE-induced hypertrophy is mediated at least in part by NCS-1-induced enhancement of Ca 2ϩ release from IP 3 Rs. Numerous signaling pathways are known to coordinate hypertrophy, including the Ca 2ϩ -dependent prohypertrophic signal molecule calcineurin and CaMKII, both of which are activated by the IP 3 R-mediated Ca 2ϩ source. 27, 28 In the present study, we observed that PE-induced activation of CaMKII and calcineurin signals were largely attenuated in Ncs1 Ϫ/Ϫ hearts. Furthermore, NCS-1-induced hypertrophy was prevented by IP 3 R, CaMKII, and calcineurin inhibitors. These data strongly indicate that NCS-1 enhances the Ca 2ϩ signal by activating IP 3 Rs, consequently mediating cardiac hypertrophy through both CaMKII and calcineurin pathways.
However, we cannot exclude the possibility that NCS-1 modulates other Ca 2ϩ signals in addition to these via IP 3 Rs. Indeed, numerous lines of evidence suggest that other Ca 2ϩ sources, such as those via transient receptor potential canonical (TRPC) channels, are important mediators of pathological hypertrophy. 29 In addition to the perinuclear region and SR, NCS-1 is also localized in the sarcolemma (Online Figure  I) and is known to bind to several other proteins, including phosphatidylinositol 4-hydroxykinase 30 and ion channels such as Kv4 K ϩ channel, 12 TRPC5, 31 and voltage-gated Ca 2ϩ channels, 13, 14 some of which are expressed in the heart. It is therefore possible that NCS-1 directly or indirectly affects sarcolemmal Ca 2ϩ entry through some ion channels. Indeed, we observed that the ATP-induced Ca 2ϩ -transient amplitude was significantly higher in WT myocytes not only without (IP 3 R-mediated Ca 2ϩ release) but also with extracellular Ca 2ϩ ( Figures 4C and 4D, respectively) , which suggests the involvement of other Ca 2ϩ signals. It has been reported that the expression of TRPC5, one of the proteins that interact with NCS-1, 31 increases in human heart failure, 32 which suggests that NCS-1 might also be involved in human heart disease. In addition, another target of NCS-1, phosphatidylinositol 4-hydroxykinase, is the key supplier of the phospholipase C substrate phosphatidylinositol 4,5-bisphosphate and can therefore regulate Ca 2ϩ signaling mediated by G-protein-coupled receptors and various ion channel functions. Such interactions may be an additional factor in the regulation of receptor stimulation-induced hypertrophy.
We proposed that NCS-1, coordinated with IP 3 Rs and CaMKII, is involved in EC coupling both in immature hearts and in hypertrophy. Many of the prohypertrophic effects of Ca 2ϩ are regulated by small EF-hand Ca 2ϩ sensor proteins, such as calmodulin, 1 chromogranin B, 33 and Ca 2ϩ and integrin-binding protein-1 (CIB1). 34 Interestingly, the expression pattern of CIB1 is high at the immature stage and reinduced in the adult heart during pathological hypertrophy, 34 similar to NCS-1, as well as IP 3 Rs 35 and CaMKII. 1 The coordinated manner of expression of these proteins implies that NCS-1, IP 3 Rs, and CaMKII may belong to a common set of genes for Ca 2ϩ regulation that control immature heart function and hypertrophy. 
Novelty and Significance
What Is Known?
• The EF-hand Ca 2ϩ -binding protein neuronal Ca 2ϩ sensor-1 (NCS-1) is recognized as an important regulator of neuronal functions such as synaptic plasticity.
• Although NCS-1 is also expressed in the heart, especially at high levels during the embryonic period, little is known about its cardiac functions.
• Mechanisms of excitation-contraction (EC) coupling in fetal and neonatal hearts are considered to be different from those in the adult heart because of the structural immaturity of the sarcoplasmic reticulum (SR) in young heart, but the detailed molecular mechanism for this is not completely understood.
What New Information Does This Article Contribute?
• We identified NCS-1 as a novel regulator of EC coupling in fetal and neonatal hearts.
• NCS-1 increases Ca 2ϩ signals through activation of inositol 1,4,5-trisphosphate receptor (IP 3 R), followed by Ca 2ϩ /calmodulindependent protein kinase II (CaMKII)-dependent signaling.
• NCS-1 expression increases in hypertrophic hearts and mediates the progression of hormone-induced hypertrophy in adult hearts.
Although NCS-1 is an important regulator of neuronal functions, its physiological and pathological roles in the heart have not yet been identified. By characterizing the cardiac phenotypes of knockout (Ncs1 Ϫ/Ϫ ) mice, we identified 2 novel functions of NCS-1 in cardiac tissues: It is a positive regulator of contraction in the developing heart and of hypertrophy in adults. In fetal and neonatal hearts, the structure and function of SR are immature; nonetheless, it is considered a primary source of Ca 2ϩ for contraction, which suggests the existence of missing factors that promote SR-dependent EC coupling in the postnatal stages. We showed that NCS-1 enhances Ca 2ϩ signals in the developing heart, mainly by promotion of IP 3 R function, followed by CaMKII signaling, which results in a large increase in the SR Ca 2ϩ content. In addition, NCS-1 expression increases in the early stages of hypertrophy in the adult heart. NCS-1 promotes progression of hypertrophy at least in part through IP 3 R activation. To the best of our knowledge, this is the first report that describes the phenotypes of Ncs1 Ϫ/Ϫ mice. Our results reveal a previously unrecognized mechanism of EC coupling in the developing heart and another regulatory mechanism for the progression of receptor stimulationelicited cardiac hypertrophy. Measurement of NFAT activity. Myocytes were plated on 24-well dishes, and 18 hours after incubation, they were infected with individual adenoviruses (multiplicity of infection (moi): 100).
Two hours later, the cells were co-transfected with 0.45 μg of pNFAT-Luc (Stratagene) and 0.05 μg of Renilla-Luc control plasmid (Promega) using Lipofectamine 2000 (Invitrogen). One day after the transfection, the medium was replaced with serum-free MEM and further incubated for 24 hours. Six hours after the stimulation, cells were lysed in reporter lysis buffer (Promega) followed by freezing and thawing, and luciferase activity was measured using the
Supplement Material
Dual-Glo luciferase assay system (Promega). The light intensity of pNFAT-Luc was normalized to that of Renilla-Luc and expressed relative to the WT control. ]I,rest is the resting Ca 2+ concentration, which was determined using Indo 1 AM as previously described 
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Antibodies and other materials. Rabbit polyclonal antibodies against NCS-1and NCX1 were prepared as described previously 4, 5 . We used rabbit polyclonal antibodies against -free solution). For general immunoblotting, mouse heart homogenates were prepared in urea buffer containing 2 mol/L urea, 10 mmol/L NaHCO 3 , 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 2% sodium dodecyl sulfate (SDS), and protease inhibitors followed by centrifugation (15,000 rpm for 10 min). Then, the immunoblots were analyzed using the same amounts of proteins after quantification (Pierce Chemical Co., Rockford, IL). The band density was quantified using Image-Pro Plus (Media Cybernetics).
Immunofluorescence. Cultured NMVMs or HEK293 cells treated for transfection or infection for 2-3 days were subjected to immunofluorescence analysis by using standard procedures.
The images of stained samples were acquired by confocal microscopy (Fluoview FV1000;
Olympus). The expression levels of ANF were quantified by the color extraction method using
Image-Pro software, as described for histological analysis.
Ventricular myocyte isolation and T-tubule imaging. Single ventricular myocytes were freshly isolated from adult male mouse hearts through standard enzymatic techniques by using Langendorf's perfusion apparatus 2 . Ventricles were also isolated from 1-week-old mice;
after sectioning, they were enzymatically dissociated into single cells 6 . For T-tubule imaging, myocytes were incubated in the non-permeable, plasma membrane-selective fluorescent dye
Online The parameters were measured at a heart rate of around 420 bpm at all ages.
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Ad-NCS-1 Phenylephrine (PE)-treatment increases NCS-1 expression from early stage. WT mice at 7 weeks of age were subjected to chronic PE or PBS infusion for 2, 4, 6 and 8 days, and heart homogenates were subjected to Western blot analysis. (B) Mean values of heart weight and body weight of WT and NCS-1 -/-mice 1 week after infusion of PE or saline. (C) NFAT-dependent luciferase activity in cultured NMVMs treated with Ad-NCS-1, 100 μM PE, 10% serum or 1 μM FK506,. a calcineurin inhibitor (n = 4/group). *P < 0.05, versus control group (determined by one-way ANOVA followed by Dunnett's test). Expression level of NCS-1 and GAPDH with or without Ad-NCS-1 infection is also shown. (D) Immunoblot analysis of the levels of total and phosphorylated ERK and p38 MAP kinases in heart homogenates from WT or Ncs1 −/− mice subjected to PE or saline infusion for 1 week. Phosphorylated protein levels were normalized to the total levels and summarized in the bar graphs (n = 8/group). 
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